IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,733,692 | +9.3% | 148,450 | -1.2% | 0.58% | +11.6% |
Q2 2023 | $6,162,912 | +12.8% | 150,205 | -1.7% | 0.52% | +8.4% |
Q1 2023 | $5,462,252 | -7.4% | 152,833 | -2.1% | 0.48% | -11.4% |
Q4 2022 | $5,896,464 | +1.4% | 156,115 | -0.6% | 0.54% | -28.1% |
Q3 2022 | $5,813,000 | +0.4% | 157,023 | +0.4% | 0.75% | +36.3% |
Q2 2022 | $5,787,000 | -0.7% | 156,323 | -0.6% | 0.55% | -16.8% |
Q1 2022 | $5,825,000 | +22.1% | 157,261 | +0.3% | 0.66% | +19.0% |
Q4 2021 | $4,771,000 | – | 156,790 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |